Put Pharmacy Costs Under the Microscope in 2020
In 2015, prescription drug spending in the United States was reported at $337 billion. It is projected that spending will reach $560 billion in 2020, a 66% increase over 5 years. Optum, the pharmacy benefit manager (PBM) subsidiary of UnitedHealthcare recently reported that there are over 150 drugs in the pipeline currently being evaluated by the FDA with 64 approvals expected in 2020. Eleven of these are “blockbuster” drugs with sales anticipated to be more than $1 billion. 70% of the new drug approvals will target specific genetic cancer mutations. The second leading area of drug development targets neurologic disorders …
https://www.epicbrokers.com/insights/put-pharmacy-costs-under-the-microscope-in-2020/